TCM
RYZB

TCG Crossover Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

TCG Crossover Management’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-869,908
Closed -$54.1M – 36
2023
Q4 		$54.1M Hold
869,908
– – 6% 5
2023
Q3 		$19.3M Buy
+869,908
New +$18.3M 2.84% 17

TCG Crossover Management's RYZB Position: Q1 2024 in Review

TCG Crossover Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 869,908 shares — an estimated $54.1M sold.

TCG Crossover Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $54.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • TCG Crossover Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • TCG Crossover Management sold 869,908 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $54.1M.
  • TCG Crossover Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • TCG Crossover Management's RayzeBio, Inc. Common Stock position peaked at $54.1M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on TCG Crossover Management's 13F filing for Q1 2024, filed 15 May 2024.